In fact, papillary thyroid carcinomas (PTCs) harboring the BRAFV600E mutation present lower SLC5A5 mRNA and NIS protein expression as well as less targeting to the basolateral membrane compared to PTCs BRAFWT (19, 24, 27). The gene discussed is SLC5A5; the disease is thyroid gland papillary carcinoma.